Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2020

01-12-2020 | Coronavirus | Opinion

Indirect implications of COVID-19 prevention strategies on non-communicable diseases

An Opinion Paper of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk Assessment in Subjects Living in or Emigrating from Low Resource Settings

Authors: Pietro A. Modesti, Jiguang Wang, Albertino Damasceno, Charles Agyemang, Luc Van Bortel, Alexandre Persu, Dong Zhao, Faical Jarraya, Ilaria Marzotti, Mohamed Bamoshmoosh, Gianfranco Parati, Aletta E. Schutte

Published in: BMC Medicine | Issue 1/2020

Login to get access

Abstract

Background

After its outbreak in China, the novel COronaVIrus Disease 19 is spreading across the globe. It is an emergency the world has never seen before.

Main text

The attention of health systems is mainly focused on COronaVIrus Disease 19 patients and on the risk that intensive care units might be overwhelmed by the serious pulmonary complications. Different countries are also attempting to establish infection prevention and control strategies which proved effective in China where the outbreak was initially reported. We reflect on important lessons to be learnt from different countries. The effects that infection prevention and control strategies, such as social distancing or isolation, can have on the care of millions of patients with non-communicable diseases, who may be indirectly affected, have not been taken into consideration so much.

Conclusions

When dealing with COronaVIrus Disease 19, policy makers and healthcare personnel should consider the indirect effects on the treatment of non-communicable diseases.
Literature
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.
11.
12.
13.
14.
15.
16.
17.
18.
Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, Huang J, He N, Yu H, Lin L, Wei S, Wu T. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA. 2020;323(19):1–9.PubMedCentralCrossRef
19.
Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395–400.PubMedPubMedCentralCrossRef
20.
Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689–97.PubMedPubMedCentralCrossRef
21.
22.
23.
24.
25.
Choi JY. Covid-19 in South Korea. Postgrad Med J. 2020 doi: 10.1136/postgradmedj-2020-137738. Online ahead of print.
26.
27.
Nagesh S, Chakraborty S. Saving the frontline health workforce amidst the COVID-19 crisis: challenges and recommendations. J Glob Health. 2020;10(1):010345.PubMedPubMedCentralCrossRef
28.
29.
30.
31.
Kluytmans-van den Bergh MFQ, Buiting AGM, Pas SD, Bentvelsen RG, van den Bijllaardt W, van Oudheusden AJG, et al. Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease 2019 in 2 Dutch hospitals during an early phase of the pandemic. JAMA Netw Open. 2020;3(5):e209673.
32.
Lai X, Wang M, Qin C, Tan L, Ran L, Chen D, et al. Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. JAMA Netw Open. 2020;3(5):e209666.PubMedPubMedCentralCrossRef
33.
34.
Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action. JMIR Public Health Surveill. 2020;6(2):e18810.PubMedPubMedCentralCrossRef
35.
36.
37.
38.
39.
40.
41.
Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020;395(10230):1137–44.PubMedPubMedCentralCrossRef
42.
43.
44.
45.
46.
47.
Pessa Valente E, Cruz Vaz da Costa Damásio L, Luz LS, da Silva Pereira MF, Lazzerini M. COVID-19 among health workers in Brazil: the silent wave. J Glob Health. 2020;10(1):010379.
48.
Hallo A, Rojas A, Hallo C. Perspective from Ecuador, the second country with more confirmed cases of coronavirus disease 2019 in South America: a review. Cureus. 2020;12(3):e7452.PubMedPubMedCentral
49.
50.
51.
52.
53.
54.
55.
56.
Rosenbaum L. The untold toll - the pandemic’s effects on patients without Covid-19. N Engl J Med. 2020;382(24):2368–71.PubMedCrossRef
57.
58.
Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13(4):e006631.PubMedCrossRef
59.
Masroor S. Collateral damage of COVID-19 pandemic: delayed medical care. J Card Surg. 2020;35(6):1345–7.PubMedCrossRef
60.
Mantica G, Riccardi N, Terrone C, Gratarola A. Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear. Public Health. 2020;183:40–1.PubMedCrossRef
61.
62.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.PubMedPubMedCentralCrossRef
63.
64.
Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Inf Secur. 2020;80(6):639–45.
65.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.PubMedPubMedCentralCrossRef
66.
Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–74.PubMedPubMedCentralCrossRef
67.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.CrossRefPubMed
68.
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.PubMedPubMedCentralCrossRef
69.
Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, Adjemian J, et al. Impact of the COVID-19 pandemic on emergency department visits - United States, January 1, 2019-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(23):699–704.PubMedPubMedCentralCrossRef
70.
71.
72.
73.
Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75(22):2871–2.PubMedPubMedCentralCrossRef
74.
75.
Brunetti ND, Molinari G, Acquistapace F, Zimotti T, Parati G, Indolfi C, et al. 2019 Italian Society of Cardiology Census on telemedicine in cardiovascular disease: a report from the working group on telecardiology and informatics. Open Heart. 2020;7(1):e001157.PubMedPubMedCentralCrossRef
76.
Tütüncü S, Honold M, Koehler K, Deckwart O, Koehler F, Haeusler KG. Non-invasive telemedical care in heart failure patients and stroke: post hoc analysis of TIM-HF and TIM-HF2 trials. ESC Heart Fail. 2020;7(3):884–91.PubMedPubMedCentralCrossRef
77.
78.
79.
Donaghy E, Atherton H, Hammersley V, McNeilly H, Bikker A, Robbins L, et al. Acceptability, benefits, and challenges of video consulting: a qualitative study in primary care. Br J Gen Pract. 2019;69(686):e586–e94.PubMedPubMedCentralCrossRef
80.
Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382(18):1679–81.PubMedCrossRef
81.
Seuren LM, Wherton J, Greenhalgh T, Cameron D, A'Court C, Shaw SE. Physical examinations via video for patients with heart failure: qualitative study using conversation analysis. J Med Internet Res. 2020;22(2):e16694.PubMedPubMedCentralCrossRef
82.
Francaise R. Décret n° 2020-227 du 9 mars 2020 adaptant les conditions du bénéfice des prestations en espèces d'assurance maladie et de prise en charge des actes de télémédecine pour les personnes exposées au covid-19. Republique Francaise; 10 mars 2020.
83.
84.
85.
86.
87.
88.
89.
90.
Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, et al. Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. 2020;26(5):309–13.PubMedCrossRef
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
Watnick S, McNamara E. On the frontline of the COVID-19 outbreak: keeping patients on long-term dialysis safe. Clin J Am Soc Nephrol. 2020;15(5):710–3.PubMedCrossRefPubMedCentral
103.
104.
McDermott MM, Newman AB. Preserving clinical trial integrity during the coronavirus pandemic. JAMA. 2020;323(21):2135–6.CrossRefPubMed
105.
106.
107.
108.
Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020;41(19):1801–3.PubMedCrossRefPubMedCentral
109.
110.
111.
Kreutz R, El-Hady Algharably EA, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Günther RiemerT, Wang J, Burnier M. Hypertension, the renin-angiotensin system and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 European Society of Hypertension COVID-19 Task Force Review of Evidence. Cardiovasc Res. Published online 15 Apr 2020. doi:10.1093/cvr/cvaa097.
112.
Metadata
Title
Indirect implications of COVID-19 prevention strategies on non-communicable diseases
An Opinion Paper of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk Assessment in Subjects Living in or Emigrating from Low Resource Settings
Authors
Pietro A. Modesti
Jiguang Wang
Albertino Damasceno
Charles Agyemang
Luc Van Bortel
Alexandre Persu
Dong Zhao
Faical Jarraya
Ilaria Marzotti
Mohamed Bamoshmoosh
Gianfranco Parati
Aletta E. Schutte
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2020
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-020-01723-6

Other articles of this Issue 1/2020

BMC Medicine 1/2020 Go to the issue

Research article

Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes

Research article

Implementation and evaluation of short peripheral intravenous catheter flushing guidelines: a stepped wedge cluster randomised trial

Research article

Processes of consent in research for adults with impaired mental capacity nearing the end of life: systematic review and transparent expert consultation (MORECare_Capacity statement)

Research article

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

Research article

Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study

Research article

Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review